KIF1A

MAY 24, 2023

A New Opportunity: the KIF1A Research Network in Action KIF1A.ORG was presented with such an opportunity by teaming up with Dr. Rebecca Shi of Stanford University, who worked to create a research laboratory course for undergraduates in the Stanford Biology department for the Spring 2023 semester. “You elegans neurons”.

Disease 98

Disease Laboratories Research Science 98

Drug Target Review

JANUARY 30, 2024

Considering the translational potential of this research to clinical applications, what are the key preclinical findings that present the 3A5C7 monoclonal antibody as a promising therapeutic option for managing morphine tolerance in humans? J Biol Chem. 2011;286(36):31731-41. Opioid Receptors. Annu Rev Med. 2016;67:433-51.

Treatment 52

Treatment Doctors Cell Biology Regulations 52

Codon

APRIL 9, 2024

Titled “Discovery of Antimalarial Chinese Herbal Medicine Under the Guidance of Mao Zedong’s Thoughts,” her presentation reported the 100 percent efficacy rate of the sample crude ether neutral extract from qinghao in both rodent and simian (primate) malaria experiments. Credit: Krzysztof Ziarnek, Kenraiz.

Drugs 138

Drugs Science Research Doctors 138

Broad Institute

OCTOBER 11, 2023

By Allessandra DiCorato October 11, 2023 In 2011, Robert Manguso was working in a cell biology lab when his mother was diagnosed with Merkel cell carcinoma, a rare and aggressive skin cancer. His mother had a presentation of the disease that suggested her immune system was already on the job.

Research 137

Research Immune Response Clinical Trials Therapies 137

Codon

OCTOBER 22, 2024

Still, shortly after I read Mastroianni’s article, Ben Recht asked on Twitter if there were any articles presenting “a positive case for peer review.” Share Asimov Press For example, one might argue that peer review is worse in medicine because reviews are largely performed by overworked doctors with limited time.

Science 107

Science Research Government Cell Biology 107

Drug Target Review

APRIL 1, 2025

I then took over management of a research group, initially running cell biology research and then preclinical development.” Dan then took over management of a cell research group, initially running a cell biology research project then preclinical development.

Disease 52

Disease Therapies Clinical Trials Cell Biology 52

Drug Target Review

JANUARY 16, 2025

5 New computational models of strain present opportunities for designing lower-strain bound conformations 16 and, combined with conventional CADD methods for assessing binding interactions with a protein, guide the optimisation of high-affinity macrocycles. Ajay N Jain Ajay is VP of Research for the Optibrium s BioPharmics Division.

Drug Development 52

Drug Development Small Molecule Drugs FDA Approval 52